Empowered Funds LLC boosted its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,227 shares of the company's stock after acquiring an additional 4,340 shares during the quarter. Empowered Funds LLC owned 0.10% of Addus HomeCare worth $2,285,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of ADUS. Creative Planning increased its position in Addus HomeCare by 5.8% during the third quarter. Creative Planning now owns 4,910 shares of the company's stock valued at $653,000 after acquiring an additional 267 shares during the last quarter. Ellsworth Advisors LLC increased its position in Addus HomeCare by 3.7% during the third quarter. Ellsworth Advisors LLC now owns 5,344 shares of the company's stock valued at $711,000 after acquiring an additional 193 shares during the last quarter. Net Worth Advisory Group purchased a new stake in Addus HomeCare during the third quarter valued at $356,000. Allspring Global Investments Holdings LLC increased its position in Addus HomeCare by 48.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 70,231 shares of the company's stock valued at $9,343,000 after acquiring an additional 22,900 shares during the last quarter. Finally, Argent Capital Management LLC grew its holdings in Addus HomeCare by 5.2% during the third quarter. Argent Capital Management LLC now owns 39,257 shares of the company's stock valued at $5,222,000 after purchasing an additional 1,947 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.
Analyst Upgrades and Downgrades
ADUS has been the subject of a number of recent analyst reports. Stephens upped their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 6th. Macquarie reaffirmed an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. StockNews.com raised Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Friday, January 24th. Finally, JMP Securities initiated coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective for the company. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Addus HomeCare has a consensus rating of "Buy" and a consensus target price of $134.22.
View Our Latest Research Report on Addus HomeCare
Insider Buying and Selling at Addus HomeCare
In other news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 over the last ninety days. Company insiders own 4.60% of the company's stock.
Addus HomeCare Stock Performance
ADUS stock traded up $2.38 during midday trading on Tuesday, reaching $115.60. 40,997 shares of the company traded hands, compared to its average volume of 159,124. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.72. The business has a 50 day moving average of $125.89 and a 200-day moving average of $127.06. The firm has a market capitalization of $2.10 billion, a price-to-earnings ratio of 26.45, a P/E/G ratio of 1.55 and a beta of 1.00.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.